Literature DB >> 4339251

Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.

J Hughes.   

Abstract

1. A method is described for the detection and assay of picogramme quantities of noradrenaline. This involves transferring Krebs solution containing noradrenaline to a cascade system where the catecholamine may be bioassayed on superfused preparations of the rabbit aorta and iliac artery.2. Electrical field stimulation of the rabbit vas deferens and portal vein caused the release, into the bathing medium, of a material which was identified by pharmacological and chemical tests as noradrenaline.3. Cocaine (0.3-5 mug/ml) caused a marked increase in noradrenaline output after electrical stimulation of the portal vein and vas deferens. This effect appeared to be maximal at a concentration of 2.4 mug/ml; when the cocaine concentration was increased above 10 mug/ml the noradrenaline output was greatly reduced.4. Phenoxybenzamine (5 mug/ml) caused a 4-8 times greater increase in noradrenaline output than cocaine; however, the increase in output due to phenoxybenzamine was much smaller in tissues pretreated with cocaine.5. Corticosterone (20 mug/ml) increased noradrenaline output by 30-40% in untreated vas deferentia, but caused a 300% increase in output in tissues pretreated with cocaine. Cocaine also caused a much greater increase in output in tissues pretreated with corticosterone than in untreated tissues.6. Treatment with pargyline plus tropolone caused a 100-200% increase in noradrenaline output; this effect was not modified by cocaine, but was abolished when the tissues were pretreated with either phenoxybenzamine or corticosterone.7. When tissues were stimulated for 240 pulses at 1-16 Hz, the output per pulse of noradrenaline increased linearly with the logarithm of the frequency of stimulation. This relationship between frequency and output was seen in both untreated tissues, and in tissues treated with cocaine, phenoxybenzamine, corticosterone or pargyline plus tropolone.8. It is concluded that cocaine enhances output by blocking the neuronal reuptake of noradrenaline, and corticosterone by blocking the extraneuronal uptake and subsequent metabolism of noradrenaline. Phenoxybenzamine acts by blocking both neuronal and extraneuronal uptake mechanisms. There appears to be a dynamic balance in the distribution of noradrenaline between the two uptake mechanisms after the release of the transmission from the nerve endings.9. It is calculated that more than 90% of the noradrenaline released by nerve stimulation (240 pulses at 2-16 Hz) is inactivated by neuronal and extra neuronal uptake mechanisms.10. It is calculated that the fraction of the total noradrenaline store that is released by one pulse at 2 Hz is 6.6 x 10(-5) in the portal vein and 5.6 x 10(-5) in the vas deferens; the corresponding values at 16 Hz were 15.9 x 10(-5) and 16.2 x 10(-5).

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4339251      PMCID: PMC1665830          DOI: 10.1111/j.1476-5381.1972.tb07285.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Frequency-dependent potentiation by various drugs of the chronotropic response of isolated cat atria to sympathetic nerve stimulation.

Authors:  C N Gillis; F H Schneider
Journal:  Br J Pharmacol Chemother       Date:  1967-08

2.  Neurotransmitter quantum released from sympathetic nerves in cat's skeletal muscle.

Authors:  L Stjärne; P Hedqvist; S Bygdeman
Journal:  Life Sci       Date:  1969-02-01       Impact factor: 5.037

3.  The release of noradrenaline by the sympathetic post-ganglionic nerves to the spleen of the cat in response to low frequency stimulation.

Authors:  B N Davies; P G Withrington
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-01

4.  Extent of release and elimination of noradrenaline at peripheral adrenergic nerve terminals.

Authors:  B Folkow; J Häggendal; B Lisander
Journal:  Acta Physiol Scand Suppl       Date:  1967

5.  Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response.

Authors:  O V Avakian; J S Gillespie
Journal:  Br J Pharmacol Chemother       Date:  1968-01

6.  Enhancement of H-3-norepinephrine uptake in rat tissues by O-methylated metabolites of catecholamines.

Authors:  L L Iversen; J E Fischer; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-10       Impact factor: 4.030

7.  Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat.

Authors:  W Haefely; A Hürlimann; H Thoenen
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

8.  Biochemical and microfluorometric studies of norepinephrine redistribution accompanying sympathetic nerve stimulation.

Authors:  C N Gillis; F H Schneider; L S Van Orden; N J Giarman
Journal:  J Pharmacol Exp Ther       Date:  1966-01       Impact factor: 4.030

9.  Some properties of the smooth muscle of rabbit portal vein.

Authors:  M E Holman; C B Kasby; M B Suthers; J A Wilson
Journal:  J Physiol       Date:  1968-05       Impact factor: 5.182

10.  Release of noradrenaline by splenic nerve stimulation and its dependence on calcium.

Authors:  S M Kirpekar; Y Misu
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

View more
  42 in total

1.  Proceedings: Is morphine inhibition to the twitch response of the mouse vas deferens mediated via noradrenaline?

Authors:  D A Jenkins; I Marshall; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Effect of blockade of noradrenaline re-uptake on evoked tritium overflow from mouse vasa deferentia and rat cortex slices.

Authors:  M el-Mas; I E Hughes
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

3.  The effects of morphine on the release of noradrenaline from the cat isolated nictitating membrane and the guinea-pig ileum myenteric plexus-longitudinal muscle preparation.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

4.  Inhibition of noradrenaline release by lysergic acid diethylamide.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

5.  Release of [3H-noradrenaline from the motor adrenergic nerves of the anococcygeus muscle by lysergic acid diethylamide, tyramine or nerve stimulation.

Authors:  J C McGrath; H J Olverman
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

6.  Inhibition of noradrenaline release by adenosine.

Authors:  A R Wakade; T D Wakade
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

7.  Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools.

Authors:  J Hughes; R H Roth
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

8.  The effects of indomethacin and eicosa-5,8,11,14-tetraynoic acid on the response of the rabbit portal vein to electrical stimulation.

Authors:  R Greenberg
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

9.  The effects of morphine on the release of noradrenaline from the mouse vas deferens.

Authors:  G Henderson; J Hughes
Journal:  Br J Pharmacol       Date:  1976-08       Impact factor: 8.739

10.  The role of calcium in the effects of noradrenaline and phenoxybenzamine on adrenergic transmitter release from atria: no support for negative feedback of release.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.